
This episode discusses personalized interventions in neuroendocrine tumors and the application of systemic therapy evidence in treatment decisions.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZBS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027. Personalized Interventions in Neuroendocrine Tumors: Applying the Latest Systemic Therapy Evidence to Guide Treatment Decisions in Community-Based Settings In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals…
Exelixis, Inc., Novartis Pharmaceuticals Corporation
Explore listener stats, chart rankings, contacts and more on the PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast podcast page.